Canadian Online Pharmacy Owner Indicted in US Federal Court for Selling Counterfeit Drugs To Americans

Canadian citizen Andrew Strempler, 38, founder of Mediplan, which fulfilled online medicine orders for ten websites, appeared in federal court in Miami on Thursday, June 14, 2012. He is expected to be arraigned on charges related to a 2005 seizure of drugs shipped by Mediplan into the US. The medications were purported to be Canadian, but US FDA officials claim the medications were actually from other countries, reports the Canadian Broadcasting Corp (CBC).

[...]

MHRA – FDA Cooperation Rousts Counterfeit Cancer Drugs

Cooperation between the U.K.’s Medicines and Healthcare Products Regulatory Agency and the USFDA brought the counterfeit Avastin distribution to light in the U.S. when MHRA officials let U.S. Food and Drug Administration agents know in December that they suspected the problem.

MHRA officials notified U.S. agents and Roche, which led Roche to test and confirm the vital life-saving medication as counterfeit last week, reported Reuters.

“As tragic as this incident is, it is to the credit of the manufacturer and law enforcement that they’ve been able to track down the source of the supplier of the counterfeit medication and contact their other customers. In many countries counterfeits make their way to patients without anyone ever being held accountable,” said Partnership for Safe Medicine’s board member Tom Kubic, President and CEO of the Pharmaceutical Security Institute.

Connie Jung, of the FDA’s Office of Drug Security, said it was possible that more than the 19 originally notified practices could be involved and warned that if a price appears to be too good to be true, it probably is.

Sources say that Montana Health Care Solutions sold the vials for 25% less than the expected cost, reports ABC World News.

Patients are beginning to be aware of the counterfeits, with growing outrage.

Said cancer patient Diane Barraza to ABC World News, “To sit in the chemo chair and watch that stuff drop into my veins,” who lives in Fullerton, Calif., with her 6-year-old daughter. “It’s all I’ve got. And it might just be water?”

[...]

FDA Warns 19 Medical Practices: Foreign Medical Distributor Gave Out Fakes, Including Fake Cancer Drugs

The FDA has issued letters to 19 US medical practices that purchased medication from a foreign supplier, Quality Specialty Products (QSP), warning that drugs distributed by QSP are known to be unapproved by the FDA, and in at least one instance verified counterfeit.

QSP, also known as Montana Health Care Solutions, has been identified by the FDA as the distributor of counterfeit Avastin. Roche AG, the manufacturer, has said that the counterfeit Avastin was tested and found to contain no active ingredient. Avastin is FDA approved for use in metastatic colorectal cancer, advanced nonsquamous non–small cell lung cancer, metastatic kidney cancer, and glioblastoma.

[...]

FDA Alert: Counterfeit Version of Avastin in U.S. Distribution

This is a reprint of the FDA Safety Alert. FDA sends letters to 19 medical practices about counterfeit product and other unapproved cancer medicines   The U.S. Food and Drug Administration (FDA) is warning health care professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical…

[...]

Counterfeit Cancer Treatment Drug Found in United States

View in a larger map A counterfeit version of the cancer therapy drug Avastin has been found in the United States, announced Roche Holding AG, a Swiss company. Vials of the medication were tested at Roche and found not to contain the active ingredients, according to Genentech, a division of Roche. A foreign supplier of…

[...]

Counterfeit Avastin Image

Images of counterfeit Avastin courtesy of Genentech.Health providers should verify product authenticity by comparing lot numbers provided by the FDA.

[...]